Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Statins promote potent systemic antioxidant effects through specific inflammatory pathways.

Shishehbor MH, Brennan ML, Aviles RJ, Fu X, Penn MS, Sprecher DL, Hazen SL.

Circulation. 2003 Jul 29;108(4):426-31. Epub 2003 Jul 14.

2.

Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.

Haendeler J, Hoffmann J, Zeiher AM, Dimmeler S.

Circulation. 2004 Aug 17;110(7):856-61. Epub 2004 Aug 2.

3.

Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy.

Shishehbor MH, Aviles RJ, Brennan ML, Fu X, Goormastic M, Pearce GL, Gokce N, Keaney JF Jr, Penn MS, Sprecher DL, Vita JA, Hazen SL.

JAMA. 2003 Apr 2;289(13):1675-80.

PMID:
12672736
4.

Antioxidant effects of statins.

Stoll LL, McCormick ML, Denning GM, Weintraub NL.

Drugs Today (Barc). 2004 Dec;40(12):975-90. Review.

PMID:
15645009
5.

Effects of atorvastatin on nuclear magnetic resonance-defined lipoprotein subclasses and inflammatory markers in patients with hypercholesterolemia.

Ikewaki K, Terao Y, Ozasa H, Nakada Y, Tohyama J, Inoue Y, Yoshimura M.

J Atheroscler Thromb. 2009 Mar;16(1):51-6. Epub 2009 Mar 5.

6.

The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients.

Thallinger C, Urbauer E, Lackner E, Graselli U, Kostner K, Wolzt M, Joukhadar C.

Int J Clin Pharmacol Ther. 2005 Dec;43(12):551-7.

PMID:
16372516
7.

[The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia].

Broncel M, Koter-Michalak M, Chojnowska-Jezierska J.

Przegl Lek. 2006;63(9):738-42. Polish.

PMID:
17479860
8.

Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.

John S, Schneider MP, Delles C, Jacobi J, Schmieder RE.

Am Heart J. 2005 Mar;149(3):473.

PMID:
15864218
9.

Effects of atorvastatin on the different phases of atherogenesis.

Rubba P.

Drugs. 2007;67 Suppl 1:17-27. Review.

PMID:
17910518
10.

Vascular effects of diet and statin in hypercholesterolemic patients.

Koh KK, Son JW, Ahn JY, Jin DK, Kim HS, Choi YM, Ahn TH, Kim DS, Shin EK.

Int J Cardiol. 2004 Jun;95(2-3):185-91.

PMID:
15193818
11.
12.

Effects of Atorvastatin on some inflammatory parameters in severe primary hypercholesterolemia.

Dobreanu M, Gălăţeanu C, Simionescu A, Deac R.

Rom J Intern Med. 2002;40(1-4):61-73.

PMID:
15526541
13.

Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation.

Hognestad A, Aukrust P, Wergeland R, Stokke O, Gullestad L, Semb AG, Holm T, Andreassen AK, Kjekshus JK.

Clin Cardiol. 2004 Apr;27(4):199-203.

14.

Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.

Bayés B, Granada ML, Lauzurica R, Pastor MC, Navarro M, Bonet J, Llopis MA, Romero R.

Transplant Proc. 2005 Nov;37(9):3808-12.

PMID:
16386546
15.

Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia.

Mazza F, Stefanutti C, Di Giacomo S, Vivenzio A, Fraone N, Mazzarella B, Bucci A.

Am J Cardiovasc Drugs. 2008;8(4):265-70.

PMID:
18690760
16.

Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels.

Horiuchi Y, Hirayama S, Soda S, Seino U, Kon M, Ueno T, Idei M, Hanyu O, Tsuda T, Ohmura H, Miida T.

J Atheroscler Thromb. 2010 Jul 30;17(7):722-9. Epub 2010 Jun 2.

17.

Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases.

Oka H, Ikeda S, Koga S, Miyahara Y, Kohno S.

Heart Vessels. 2008 Jul;23(4):249-56. doi: 10.1007/s00380-008-1038-9. Epub 2008 Jul 23.

PMID:
18649055
18.

In vivo confirmation of the role of statins in reducing nitric oxide and C-reactive protein levels in peripheral arterial disease.

Aguilar EM, Miralles Jde H, González AF, Casariego CV, Moreno SB, García FA.

Eur J Vasc Endovasc Surg. 2009 Apr;37(4):443-7. doi: 10.1016/j.ejvs.2008.12.009. Epub 2009 Feb 10.

19.

Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia.

Ercan E, Tengiz I, Altuglu I, Sekuri C, Aliyev E, Ercan HE, Akin M.

Kardiol Pol. 2004 May;60(5):454-8.

PMID:
15247960
20.

Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase.

Haramaki N, Ikeda H, Takenaka K, Katoh A, Sugano R, Yamagishi S, Matsuoka H, Imaizumi T.

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1471-7. Epub 2007 Mar 22.

Supplemental Content

Support Center